Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021

Victoria Indenbaum*, Yaniv Lustig, Ella Mendelson, Yael Hershkovitz, Aharona Glatman-Freedman, Lital Keinan-Boker, Ravit Bassal

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0-15 years from January 2020 to March 2021. Seropositivity was 1.8-5.5 times higher than COVID-19 incidence rates based on PCR testing. We found that SARS-CoV-2 infection among children is more prevalent than previously thought and emphasise the importance of seroprevalence studies to accurately estimate exposure.

Original languageEnglish
Article number2101040
JournalEurosurveillance
Volume26
Issue number48
DOIs
StatePublished - 2 Dec 2021

Fingerprint

Dive into the research topics of 'Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021'. Together they form a unique fingerprint.

Cite this